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Abstract
The pandemic influenza virus (2009 H1N1) was recently introduced into the human population. The hemagglutinin (HA)
gene of 2009 H1N1 is derived from ‘‘classical swine H1N1’’ virus, which likely shares a common ancestor with the human
H1N1 virus that caused the pandemic in 1918, whose descendant viruses are still circulating in the human population with
highly altered antigenicity of HA. However, information on the structural basis to compare the HA antigenicity among 2009
H1N1, the 1918 pandemic, and seasonal human H1N1 viruses has been lacking. By homology modeling of the HA structure,
here we show that HAs of 2009 H1N1 and the 1918 pandemic virus share a significant number of amino acid residues in
known antigenic sites, suggesting the existence of common epitopes for neutralizing antibodies cross-reactive to both HAs.
It was noted that the early human H1N1 viruses isolated in the 1930s–1940s still harbored some of the original epitopes that
are also found in 2009 H1N1. Interestingly, while 2009 H1N1 HA lacks the multiple N-glycosylations that have been found to
be associated with an antigenic change of the human H1N1 virus during the early epidemic of this virus, 2009 H1N1 HA still
retains unique three-codon motifs, some of which became N-glycosylation sites via a single nucleotide mutation in the
human H1N1 virus. We thus hypothesize that the 2009 H1N1 HA antigenic sites involving the conserved amino acids will
soon be targeted by antibody-mediated selection pressure in humans. Indeed, amino acid substitutions predicted here are
occurring in the recent 2009 H1N1 variants. The present study suggests that antibodies elicited by natural infection with the
1918 pandemic or its early descendant viruses play a role in specific immunity against 2009 H1N1, and provides an insight
into future likely antigenic changes in the evolutionary process of 2009 H1N1 in the human population.
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Introduction
In April 2009, pandemic (H1N1) 2009 influenza virus (2009
H1N1) was first found in patients with febrile respiratory illness in
the United States and Mexico, and has spread rapidly across the
world by human-to-human transmission. On the 11th of June
2009, the World Health Organization declared a global pandemic
of 2009 H1N1 infection. H1N1 influenza virus caused a pandemic
in 1918 (1918 H1N1) [1], and its descendant virus with highly
altered antigenicity of the viral surface protein, hemagglutinin
(HA) has been causing ‘‘seasonal flu’’ in humans.
The 2009 H1N1 resulted from genetic reassortment between
the recently circulating swine H1 viruses in North America and
the avian-like swine viruses in Europe [2]. Phylogenetic analysis
showed that the HA gene of 2009 H1N1 was derived from the so-
called ‘‘classical swine H1N1’’ virus, which likely shares a common
ancestor with the recent human H1N1 virus [2]. Accordingly, it
has been reported that the early strains of the classical swine H1N1
virus, which was first identified in North America in 1930, were
antigenically similar to the prototype strain of 1918 H1N1, A/
South Carolina/1/1918 (SC1918), detected from a few victims of
the pandemic in 1918 [3,4]. Since antigenic changes occur more
slowly in swine than in the human population [5], HA of the
classical swine H1N1 virus was antigenically highly conserved until
the late 1990s [4,6], raising the possibility that the recently
emerged 2009 H1N1 may still retain an antigenic structure similar
to that of SC1918 and the early isolates of its descendants.
In this study, we generated three-dimensional (3D) structures of
the HA molecules of 1918 H1N1, its descendent, recent seasonal
H1N1 viruses, and 2009 H1N1, and compared their antigenic
structures to look for evidence for the existence of shared epitopes
for neutralizing antibodies. Since the 2009 H1N1 HA antigenic
sites will be targeted by antibody-mediated selection pressure in
humans in the near future, we further discuss possible directions of
antigenic changes in the evolutionary process of this pandemic
virus.
Results and Discussion
It is known that the H1 HA molecules have four distinct
antigenic sites: Sa, Sb, Ca, and Cb [7,8,9,10] (Figure 1). As a
result, these sites consist of the most variable amino acids in the
HA molecule of the seasonal human H1N1 viruses that have been
subjected to antibody-mediated immune pressure since its
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8553Figure 1. Comparison of the structures of antigenic sites on the HA molecules among 1918 H1N1 (SC1918), recent seasonal H1N1
(BR2007), and 2009 H1N1 (CA2009). Three-dimensional models of the H1 HA molecules of SC1918, BR2007, and CA2009 were constructed based
on the HA crystal structures of A/South Carolina/1/18, A/Puerto Rico/8/34, and A/swine/Iowa/30, respectively (PDB codes: 1RUZ, 1RU7, and 1RUY,
respectively). Models with solvent-accessible surface representation were generated by a molecular modeling method as described in the Methods
section. Molecular surface of the HA trimers viewed on its side (upper) and top (lower) are shown (A). One monomer (center) is colored gray and the
others are colored dark gray. The antigenic sites, Sa (light pink), Sb (light blue), Ca (pale green), and Cb (light orange) are indicated on the model of
SC1918 HA. The spatial locations of amino acid residues that are distinct from those of SC1918 HA are shown in red on the models of BR2007 and
CA2009 HAs. Each amino acid residue is mapped on the close-up views of each antigenic site of SC1918, BR2007, and CA2009 HAs (B). The Ca site is
divided into subregions, Ca1 and Ca2. Amino acids are colored by the default ClustalX color scheme [29]: Trp, Leu, Val, Ile, Met, Phe, and Ala (blue); Lys
and Arg (red); Thr, Ser, Asn, and Gln (green); Cys (pink); Asp and Glu (magenta); Gly (orange); His and Tyr (cyan); Pro (yellow).
doi:10.1371/journal.pone.0008553.g001
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antigenic sites of 2009 H1N1, 3D structures of the HA molecules
of SC1918, the recent seasonal human H1N1 virus A/Brisbane/
59/2007 (BR2007), and 2009 H1N1 A/California/04/2009
(CA2009) [2] were constructed by a homology modeling
approach, and compared by mapping all the amino acid residues
that were distinct from those of SC1918 HA (Figure 1 and Table
S1). We found that most of these antigenic sites of BR2007 HA
predominantly contained altered amino acid residues if compared
with SC1918. By contrast, amino acid residues at these positions
were relatively conserved in CA2009 HA. Notably, the Sa and Sb
sites that contain many amino acids involved in neutralizing
epitopes near the receptor binding pockets [8,10] remain almost
intact in CA2009 HA (Table 1), suggesting that antibodies raised
by natural infection with SC1918 or its antigenically related
descendant viruses play a role in specific immunity against
CA2009.
We then constructed 3D structures of the representative strains
of seasonal H1 viruses that had been isolated since 1934, and
tracked the amino acid substitutions on their HA molecules
(Figure 2 and Figure S1). We confirmed that amino acid
substitutions associated with the antigenic changes gradually
accumulated on the globular head region of HA and were
distributed over four distinct antigenic sites. However, it was noted
that the early isolates represented by the A/Puerto Rico/8/1934
and A/Bellamy/1942 strains, but not the strains isolated after the
Table 1. Amino acid similarity in the HA antigenic sites
among recent seasonal H1N1 (BR2007), 2009 H1N1 (CA2009),
and 1918 H1N1 (SC1918).
Antigenic
sites
No. amino acids
involved No. of amino acids identical to SC1918
BR2007 CA2009
Sa 13 8 12
Sb 12 4 10
Ca 19 13 13
Cb 6 2 5
doi:10.1371/journal.pone.0008553.t001
Figure 2. Amino acid substitutions associated with antigenic changes of seasonal human H1N1 virus HAs. All models were generated
and shown by a molecular modeling method as described in the Methods section and the legend of Figure 1.
doi:10.1371/journal.pone.0008553.g002
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neutralizing epitopes in the Sa and Sb sites (Figure 2). It seems
likely that most of the amino acids on these antigenic sites were
eventually substituted in the late 1940s (Figure S1).
It is well-documented that antigenic changes of HA occasionally
result in the acquisition of carbohydrate side chains on the HA
molecule [8,11]. Since the carbohydrate side chains in the vicinity
of antigenic sites mask the neutralizing epitopes on the HA surface,
amino acid substitutions associated with acquisition of carbohy-
drate chains are believed to efficiently generate antigenic variants.
Accordingly, recent seasonal H1N1 viruses have acquired 4–5 N-
glycosylation sites (Asn-Xaa-Ser/Thr, where Xaa is any amino
acid except Pro) in the globular head region of HA [12,13],
whereas SC1918 HA had only one site, at Asn 104 (Figure 3).
Interestingly, CA2009 also has a single potential N-glycosylation
siteatthesamepositionintheglobularheadregionofHA(Figure3),
despite the fact that the classical swine H1N1 virus emerged in the
early 1900s and was circulating in the pig population until recently.
Thispromptedus to estimate the potentialof 2009 H1N1 to acquire
additional N-glycosylation sites on its HA, which may be related to
its future evolutionary process in the human population. We
previously defined a three-codon motif that becomes an N-
glycosylation site with a single-nucleotide mutation as ‘‘Cand1’’,
and suggested that the presence of the Cand1 sites in the HA
sequence is one of the key factors for human influenza A viruses to
rapidly acquire N-glycosylation sites during the early epidmic in the
human population [13]. We compared the number of the Cand1
sites in the HA globular head region between SC1918 and CA2009
(Figure 3 and Table S1). We found that CA2009 HA possessed
three Cand1 sites on the antigenic sites Sa and Ca, all of which were
alsopresentatthe same positioninSC1918HA(positionsofthe first
Asn residue, 177, 179, and 184). Of these, the Cand1 sites with
positions at 177 and 179 had actually become potential N-
glycosylation sites in human H1N1 viruses, although these two
sites did not exist concurrently [12]. It is noted that these two Cand1
sites are still present on the surface of CA2009 HA, suggesting the
likelihood of additional N-glycosylation at these sites during future
antigenic changes of 2009 H1N1 HA.
Figure 3. Comparison of the N-glycosylation potential of HA between SC1918 and CA2009. Residues shown in green represent Asn at the
actually existing N-glycosylation sites. Residues shown in orange or blue represent the amino acids in Cand1 sites that require a nucleotide
substitution to produce N-glycosylation sites. Residues shown in blue represent the amino acids that were actually substituted, resulting in the
acquisition of N-glycosylation sites during the antigenic evolution of human H1N1 viruses. Numbers in parentheses show the positions of Asn
residues that may be linked to carbohydrate chains, if respective Cand1 sites mutate to have N-glycosylation sites. All models were generated as
described in the Methods section and the legend of Figure 1.
doi:10.1371/journal.pone.0008553.g003
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homology modeling method to map amino acid residues on the
antigenic sites of HA. When compared to the presentation of
simple primary sequences, the 3D presentation has following
advantages: (a) There are several amino acid residues that are
buried beneath the surface of the HA molecule, even if they are
included in the antigenic sites described by the primary amino acid
sequences. Since such amino acid residues do not directly
contribute to the interaction with antibodies, the surface structures
of antigenic sites that are accessible for antibodies can be
compared more precisely in the presentation by 3D models than
by the primary amino acid sequence. (b) An epitope likely consists
of multiple amino acid residues belonging to different antigenic
regions presented by the primary amino acid sequence. Such
conformational epitopes can be illustrated only by the 3D
presentation. (c) One of the purposes of this study is to provide a
structural basis to confirm antigenic similarity between the 1918
H1N1 and the pandemic 2009 H1N1 viruses. For this purpose, we
employed a homology modeling method rather than simply
mapping on the existing crystal structure (e.g. 1918 H1N1 HA),
since this method is generally used to generate a 3D structure of a
protein molecule if there is no available crystal structure of the
target protein [14]. Thus, we believe that this method produces
more likely HA structure models of the viruses whose HA crystal
structure are not available (e.g. CA2009). In fact, our homology
modeling approach suggests that several amino acid residues were
occasionally buried beneath or exposed to the surface of HA
molecule, depending on the substitutions found in the viruses
examined (Figure 1B and Figure S1). The homology modeling
approach might enable us to analyze such dynamics of antigenic
changes at molecular levels.
Our analysis indicated that 2009 H1N1 had undergone less
significant antigenic changes of HA in the pig population than
human H1N1 virus since their emergence in the early 1900s. The
Centers for Disease Control and Prevention reported that
vaccination with recent (2005–2009) human H1N1 viruses was
unlikely to provide protection against 2009 H1N1 [15]; however,
cross-reactive antibodies were detected in 33% of people aged 60
and over. Another report showed that appreciable neutralizing
antibodies against CA2009 were present in the sera collected from
individuals born before 1918 [16]. Our 3D models provide a
protein-structural basis supporting these observations, and further
suggest that infection with the 1918 H1N1 or early human H1N1
viruses (viruses present before the 1940s), but not with antigen-
ically divergent human H1N1 viruses circulating after the 1950s,
elicited cross-neutralizing antibodies to 2009 H1N1.
This virus will soon be subjected to complex immunological
selection pressure by the antibody response that will be induced in
the human population by vaccination and/or natural infection
with homologous viruses, and pre-existing immunity cross-reactive
to the early descendants of 1918 H1N1. In the present study, we
showed that the antigenic structure of 2009 H1N1 HA might still
be similar, at least in part, to that of the 1918 H1N1 HA. We
speculate that the 2009 H1N1 HA antigenic sites involving the
conserved amino acids will soon be targeted by neutralizing
antibodies in humans. Thus, it is of interest to monitor whether
these antigenic sites of 2009 H1N1 will undergo similar patterns of
amino acid substitutions to those seen in seasonal H1N1 viruses
during its epidemic period (Figure 4). Interestingly, we found that
some of the recent variants of the 2009 H1N1 virus (as of
November 3, 2009) have indeed undergone substitutions identical
to those predicted in Figure 4. Although the present study still
needs to be supported by experimental data, our approach may
provide new perspectives on collective immunity against 2009
H1N1 and an insight into future antigenic changes of this new
human pandemic influenza virus.
Methods
Sequence Data of HA Genes
Nucleotide sequences for HA genes of SC1918 (AF117241),
BR2007 (CY030230), CA2009 (FJ966082), A/Puerto Rico/8/
1934/Mount Sinai (AF389118), A/Bellamy/1942 (CY009276),
A/Albany/4836/1950 (CY021701), A/USSR/90/1977
(DQ508897), A/Singapore/6/1986 (CY020477), A/Texas/36/
1991 (AY289927), and A/Hong Kong/1035/1998 (AF386777)
[2,3,17,18,19,20] were obtained from Influenza Virus Resource at
the National Center for Biotechnology Information (NCBI)
(http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html).
Molecular Modeling
MODELLER 9v6 [21] was used for homology modeling of HA
structures. After one hundred models of the HA trimer were
generated, the model was chosen by a combination of the
MODELLER objective function value and the discrete optimized
protein energy (DOPE) statistical potential score [22]. After
addition of hydrogen atoms, the model was refined by energy
minimization (EM) with the minimization protocols in the
Discovery Studio 2.1 software package (Accelrys, San Diego, CA)
using a CHARMm force field. Steepest descent followed by
conjugate gradient minimizations was carried out until the root
mean square (rms)gradientwas less than or equal to 0.01kcal/mol/
A ˚. The generalized Born implicit solvent model [23,24] was used to
model the effects of solvation. The HA model was finally evaluated
by using PROCHECK [25], WHATCHECK [26], and VERIFY-
3D [27]. All figures are shown as a solvent-accessible surface
representation prepared by PyMOL (DeLano Scientific LLC) [28].
All HA structures constructed by a homology modeling method are
available in Supplementary Files S1, S2, S3, S4, S5, S6, S7, and S8.
Sequence Data Analyses for N-Glycosylation Sites
Custom-made programs were developed with the Ruby
language and used for investigating the numbers of potential N-
glycosylation sites and candidate codons (Cand1) in HA sequences.
The programs are available upon request.
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